BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 20 filers reported holding BELLEROPHON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,783 | -43.3% | 127,723 | -1.7% | 0.00% | – |
| Q2 2023 | $89,615 | -88.2% | 129,876 | +34.8% | 0.00% | – |
| Q1 2023 | $760,194 | +739.4% | 96,349 | -4.2% | 0.00% | – |
| Q4 2022 | $90,562 | -17.7% | 100,625 | 0.0% | 0.00% | – |
| Q3 2022 | $110,000 | -11.3% | 100,625 | 0.0% | 0.00% | – |
| Q2 2022 | $124,000 | -56.5% | 100,625 | -16.6% | 0.00% | – |
| Q1 2022 | $285,000 | -24.6% | 120,689 | -0.8% | 0.00% | – |
| Q4 2021 | $378,000 | -22.9% | 121,670 | +0.9% | 0.00% | – |
| Q3 2021 | $490,000 | -13.1% | 120,620 | +3.6% | 0.00% | – |
| Q2 2021 | $564,000 | -66.2% | 116,482 | -63.8% | 0.00% | – |
| Q1 2021 | $1,670,000 | -20.4% | 321,782 | +2.3% | 0.00% | – |
| Q4 2020 | $2,098,000 | -28.1% | 314,617 | +9.8% | 0.00% | – |
| Q3 2020 | $2,916,000 | -18.6% | 286,457 | +0.4% | 0.00% | – |
| Q2 2020 | $3,584,000 | – | 285,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 69,000 | $85,000 | 0.10% |
| Sepio Capital, LP | 23,800 | $29,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 20,000 | $25,000 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 500 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,000 | $1,000 | 0.00% |
| US BANCORP \DE\ | 1,221 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200,057 | $246,000 | 0.00% |
| NORTHERN TRUST CORP | 28,097 | $35,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 64,355 | $79,000 | 0.00% |